Glaucoma Eye Drops, Dry Eye, and Sleep Quality: Exploring Hidden Connections and What Patients Can Do

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/glaucoma-eye-drops-dry-eye-and-sleep-quality-exploring-hidden-connections-and-what-patients-can-do

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Introduction People with glaucoma often rely on daily eye drops to protect their vision. These medications lower eye pressure, but over months or years they can sometimes irritate the ocular surface (the cornea and surrounding tissues). Many glaucoma drops contain preservatives or active ingredients that may dry out the eyes or cause inflammation. At the same time, dry eye disease (insufficient or poor-quality tear film) is common and can disrupt sleep. In fact, recent research shows that people with dry eye often report worse sleep quality than those without it () (). This article explores how glaucoma eye drops might contribute to dry eye and whether that could affect sleep – especially REM (rapid eye movement) sleep, when the eyes rock back and forth under closed lids. We’ll look at what studies say about these links and suggest practical steps patients can take. How Glaucoma Eye Drops Affect the Ocular Surface Glaucoma eye drops protect vision but can irritate the eye. This irritation usually comes from the medicine’s ingredients or the preservatives used to keep the drops sterile. For example, benzalkonium chloride (BAK) is a very common preservative in glaucoma medications, and it is known to damage the tear film and cells on the eye surface () (). Even small doses of BAK can break apart the protective tear layer, causing burning, stinging, redness or a foreign-body sensation () (). Newer formulations try to minimize this by using gentler preservatives (like SofZia or Polyquad ()) or going preservative-free. Clinical studies show that patients on preservative-containing eyedrops report much more irritation and surface damage than those using preservative-free versions () (). Besides preservatives, the active ingredients of glaucoma drugs can also affect tear production. For instance, beta-blocker drops (like timolol) can reduce tear secretion and cause dryness. Other drugs (carbonic anhydrase inhibitors, alpha agonists, and even some prostaglandin analogs) may also cause mild burning or redness in sensitive patients () (). Over time, the chronic use of these medicines can inflame the ocular surface and even change the glands that keep the eyes lubricated. A Korean study noted that glaucoma medications – not just their preservatives – can cause chronic ocular surface inflammation and alter the tear-producing meibomian glands (). Several studies have confirmed that glaucoma patients tend to show signs of dry eye. For example, Sahlu and colleagues found that people on multi-drop glaucoma therapy had significantly more dry eye findings (like shorter tear break-up time and more corneal staining) than control subjects (). The Pakistani study reported lower tear film stability (short TBUT) and higher corneal staining in glaucoma patients, especially those using multiple medications per day (). Importantly, more drops per day or more medications generally means worse ocular surface effects. In one trial, patients on glaucoma drugs had a significant drop in the lipid layer of their tears and worse dry-eye symptom scores in the first 6–12 months of treatment () (). In short, long-term use of glaucoma eye drops – especially in polypharmacy – can l